The Democratic Progressive Party cabinet in Taiwan has recently approved a far reaching package of draft revisions to Taiwan’s cosmetics law. It plans to support the regulatory system with international practice and better consumer safety. In India Central Drugs Standards Control Organization (CDSCO) is the regulatory authority for Cosmetic Registration and Import. We (Morulaa HealthTech Pvt Tech) provide assistance in applying Cosmetic Registration Certificate, Master importer (Customs Clearance, Supply Chain and Logistics), analysis and testing of cosmetics.
The cabinet approved the proposed set of revisions to the renamed Act for Control of Cosmetic Safety and Hygiene. It marks the first major changes to Taiwan cosmetics regulations since 2002.
During the meeting the premier of Republic of China Lin Chuan said, if approved, the draft bill “will allow our cosmetic hygiene and safety regulatory system to link up with international practice”.
Among the revisions are proposals to:
- It allow cosmetics sites to register launches or new imports by submitting product information files containing essential product, producer or importer information
- Revise rules on how essential detail must be displayed on packaging or containers
- Require details to be listed on the outside packaging or containers of cosmetic products. This information is specified in Article 7. All information must be in Chinese or international symbols, except the identification of ingredients. These may be in English
- Mandate that the manufacturing of cosmetic products should be in line with cosmetic good manufacturing practices (CGMP) issued by the Ministry of Health and Welfare
- Central government agencies including the Ministry of Economic Affairs, the authority to carry out related factory inspections.
Other News
India Medical Device Pricing Strategy: Ensuring Growth & Affordability
India’s National Pharmaceutical Pricing Authority (NPPA) is developing a specialized India medical device pricing strategy for medical devices, transitioning away from the conventional drug-centric framework. This innovative strategy will incorporate international pricing tactics tailored to […]
Read MoreImports of High-Value Medical Equipment
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC Committee: Pioneering Medical Approvals
New important article released by Central Drugs Standard Control Organization (CDSCO) titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing materials, […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
